Institutional investors purchased a net $593.2 thousand shares of MNOV during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 19.92% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NATIONWIDE FUND ADVISORS Sold 1.9 Thousand shares of MediciNova Inc